Study of icotrokinra for active psoriatic arthritis
Treatments studied
Part of Bones, joints & muscles, Skin clinical trials.
This trial tests a new medication called icotrokinra for people with active psoriatic arthritis (PsA). It aims to see how well the drug works and if it is safe, including for those who have tried other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have active psoriatic arthritis (PsA) with at least 3 swollen joints and 3 tender joints, and have tried at least one previous treatment like non-biologic DMARDs, apremilast, or only one biologic agent.
- You have been diagnosed with PsA for at least 3 months.
- You have at least one plaque of psoriasis that is about the size of a coin (2 cm or larger) or nail changes from psoriasis.
- You do not have a history of cancer within the last 5 years (except some skin cancers), or any serious uncontrolled health problems.
- You are not allergic to icotrokinra or its ingredients.
- If you could become pregnant, you must have a negative pregnancy test before starting and use effective contraception.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called JNJ-88545223 to see if it can reduce joint pain, swelling, and skin plaques in people with active psoriatic arthritis. It may help if you have both joint symptoms and psoriasis.
This study tests a new medicine called icotrokinra for people with moderate to severe Crohn's disease who have not responded well to other treatments. It aims to see if icotrokinra can help reduce symptoms and improve gut health.
This trial tests a new oral medication, icotrokinra, for people with moderately to severely active ulcerative colitis. It may be an option if you have not responded well enough to standard treatments or newer advanced therapies.
This study tests an oral medicine called zasocitinib for people with psoriatic arthritis who have not had enough relief from other treatments. It may help reduce joint pain and skin symptoms.
This trial tests an oral medication called zasocitinib for adults with psoriatic arthritis who have not tried biologic medicines before. It aims to see if the drug can improve joint pain, swelling, and skin symptoms.
This trial tests a new drug called tulisokibart for people with psoriatic arthritis (PsA), a condition that causes joint pain and skin plaques. It may help if you have not tried certain biologic medications or if they did not work well.
Hear when a new Arthritis, Psoriatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.